Cargando…
Cabozantinib Reverses Topotecan Resistance in Human Non-Small Cell Lung Cancer NCI-H460/TPT10 Cell Line and Tumor Xenograft Model
Cabozantinib (CBZ) is a small molecule tyrosine kinase receptor inhibitor, which could also inhibit the ABCG2 transporter function. Therefore, CBZ could re-sensitize cancer cells that are resistant to ABCG2 substrate drugs including topotecan (TPT). However, its reversal effect against TPT resistanc...
Autores principales: | Lei, Zi-Ning, Teng, Qiu-Xu, Gupta, Pranav, Zhang, Wei, Narayanan, Silpa, Yang, Dong-Hua, Wurpel, John N. D., Fan, Ying-Fang, Chen, Zhe-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019832/ https://www.ncbi.nlm.nih.gov/pubmed/33829017 http://dx.doi.org/10.3389/fcell.2021.640957 |
Ejemplares similares
-
Establishment and Characterization of a Topotecan Resistant Non-small Cell Lung Cancer NCI-H460/TPT10 Cell Line
por: Lei, Zi-Ning, et al.
Publicado: (2020) -
Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) Inhibitor
por: Wu, Zhuo-Xun, et al.
Publicado: (2021) -
Sufentanil impairs autophagic degradation and inhibits cell migration in NCI-H460 in vitro
por: Jiang, Hui, et al.
Publicado: (2019) -
Combined anticancer activity of osthole and cisplatin in NCI-H460 lung cancer cells in vitro
por: XU, XIAO-MAN, et al.
Publicado: (2013) -
Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cells
por: Hövelmann, S, et al.
Publicado: (2004)